Found 4 hits of ic50 for monomerid = 50194697 Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Tyrosine-protein kinase Lck
(Homo sapiens (Human)) | BDBM50194697
(4-methyl-N-(2-(3-methyl-2-oxoimidazolidin-1-yl)-5-...)Show SMILES CNc1ncc2cc(ccc2n1)-c1cc(ccc1C)C(=O)Nc1cc(ccc1N1CCN(C)C1=O)C(F)(F)F Show InChI InChI=1S/C28H25F3N6O2/c1-16-4-5-18(13-21(16)17-6-8-22-19(12-17)15-33-26(32-2)35-22)25(38)34-23-14-20(28(29,30)31)7-9-24(23)37-11-10-36(3)27(37)39/h4-9,12-15H,10-11H2,1-3H3,(H,34,38)(H,32,33,35) | PDB
UniProtKB/SwissProt
antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
Amgen, Inc.
Curated by ChEMBL
| Assay Description Inhibition of Lck by HTRF kinase assay |
J Med Chem 49: 5671-86 (2006)
Article DOI: 10.1021/jm0605482 BindingDB Entry DOI: 10.7270/Q29G5MFD |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 14
(Homo sapiens (Human)) | BDBM50194697
(4-methyl-N-(2-(3-methyl-2-oxoimidazolidin-1-yl)-5-...)Show SMILES CNc1ncc2cc(ccc2n1)-c1cc(ccc1C)C(=O)Nc1cc(ccc1N1CCN(C)C1=O)C(F)(F)F Show InChI InChI=1S/C28H25F3N6O2/c1-16-4-5-18(13-21(16)17-6-8-22-19(12-17)15-33-26(32-2)35-22)25(38)34-23-14-20(28(29,30)31)7-9-24(23)37-11-10-36(3)27(37)39/h4-9,12-15H,10-11H2,1-3H3,(H,34,38)(H,32,33,35) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | n/a |
Amgen, Inc.
Curated by ChEMBL
| Assay Description Inhibition of p38-alpha by HTRF kinase assay |
J Med Chem 49: 5671-86 (2006)
Article DOI: 10.1021/jm0605482 BindingDB Entry DOI: 10.7270/Q29G5MFD |
More data for this Ligand-Target Pair | |
Vascular endothelial growth factor receptor 2
(Homo sapiens (Human)) | BDBM50194697
(4-methyl-N-(2-(3-methyl-2-oxoimidazolidin-1-yl)-5-...)Show SMILES CNc1ncc2cc(ccc2n1)-c1cc(ccc1C)C(=O)Nc1cc(ccc1N1CCN(C)C1=O)C(F)(F)F Show InChI InChI=1S/C28H25F3N6O2/c1-16-4-5-18(13-21(16)17-6-8-22-19(12-17)15-33-26(32-2)35-22)25(38)34-23-14-20(28(29,30)31)7-9-24(23)37-11-10-36(3)27(37)39/h4-9,12-15H,10-11H2,1-3H3,(H,34,38)(H,32,33,35) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 461 | n/a | n/a | n/a | n/a | n/a | n/a |
Amgen, Inc.
Curated by ChEMBL
| Assay Description Inhibition of KDR by HTRF kinase assay |
J Med Chem 49: 5671-86 (2006)
Article DOI: 10.1021/jm0605482 BindingDB Entry DOI: 10.7270/Q29G5MFD |
More data for this Ligand-Target Pair | |
Tyrosine-protein kinase JAK3
(Homo sapiens (Human)) | BDBM50194697
(4-methyl-N-(2-(3-methyl-2-oxoimidazolidin-1-yl)-5-...)Show SMILES CNc1ncc2cc(ccc2n1)-c1cc(ccc1C)C(=O)Nc1cc(ccc1N1CCN(C)C1=O)C(F)(F)F Show InChI InChI=1S/C28H25F3N6O2/c1-16-4-5-18(13-21(16)17-6-8-22-19(12-17)15-33-26(32-2)35-22)25(38)34-23-14-20(28(29,30)31)7-9-24(23)37-11-10-36(3)27(37)39/h4-9,12-15H,10-11H2,1-3H3,(H,34,38)(H,32,33,35) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 987 | n/a | n/a | n/a | n/a | n/a | n/a |
Amgen, Inc.
Curated by ChEMBL
| Assay Description Inhibition of Jak3 by HTRF kinase assay |
J Med Chem 49: 5671-86 (2006)
Article DOI: 10.1021/jm0605482 BindingDB Entry DOI: 10.7270/Q29G5MFD |
More data for this Ligand-Target Pair | |